Our research presents compelling evidence that assessing cytokine concentrations, specifically IL-8 and VEGF, can be useful in predicting hematological complications such as lymphopenia, neutropenia, anemia, infection, and polyneuropathy in MM patients. This evidence concerns the gene CXCL8 and polyneuropathy.